BGLC

BioNexus Gene Lab Corp. (BGLC) ESG Analysis Analysis (2026)

Invetso Score: 5.6/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.4 (Moderate)

R&D intensity is modest at 1.7% of revenue, suggesting limited environmental innovation capacity versus peers with heavier clean-technology investment.

No disclosed environmental metrics in the provided data indicate stronger operational transparency than peers, but the absence of evidence limits relative differentiation.

Low leverage can support funding flexibility for environmental compliance and upgrades, yet it does not itself indicate superior environmental management versus peers.

The available metrics do not show material environmental liabilities or transition exposures, leaving BGLC positioned around peer-average on environmental risk visibility.

Social

Score:

Zero stock-based compensation to revenue suggests restrained dilution and potentially simpler employee incentive structures, but it provides little direct evidence of stronger social practices versus peers.

The provided data contain no workforce, safety, diversity, or customer-responsibility disclosures, which limits confidence in any social advantage relative to peers.

Modest R&D spending may constrain product or service development that could improve stakeholder outcomes, leaving social positioning broadly average versus peers.

Without controversy or labor metrics, BGLC appears neither clearly advantaged nor disadvantaged on social factors compared with peers.

Governance

Score:

Very low debt-to-equity of 0.03 indicates conservative capital structure, which generally reduces creditor pressure and supports governance flexibility versus leveraged peers.

Net debt to EBITDA of 0.42 suggests limited balance-sheet strain, lowering refinancing risk and improving governance resilience relative to more indebted peers.

Zero stock-based compensation to revenue points to limited equity dilution, which can align management and shareholder interests better than peers with heavier issuance.

However, the absence of board, audit, ownership, and control disclosures prevents a stronger governance score despite the favorable leverage profile.

Overall Score

Score:

BGLC’s ESG profile is broadly average versus peers, with governance modestly supported by a conservative balance sheet but limited disclosure across environmental and social factors.

Score Driver: Conservative Leverage Supports Governance Resilience, But Sparse ESG Disclosure Prevents A Stronger Relative Position.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on BioNexus Gene Lab Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →